AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Jubivilda 50 M Tablet SR

Prescription Icon
Prescription Required

Marketer

Jubilant Generics Limited

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Jubivilda 50 M Tablet SR

Diabexe 50mg Extended-Release tablets combine two active ingredients to manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent severe diabetic complications like vision impairment and kidney disease, potentially lowering the risk of stroke and heart attack. Diabexe 50mg ER may be used independently or in conjunction with other anti-diabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on your health status, blood glucose readings, and existing medications. Consuming it with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes benefits; discontinuation should only occur under medical supervision. Effective blood sugar control is crucial for mitigating future complications. Maintaining the prescribed diet and exercise plan is essential for successful diabetes management, as lifestyle plays a critical role in disease control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential side effect, particularly when combined with insulin or sulfonylureas; understand its symptoms and management. This medication isn't suitable for all individuals. Inform your doctor of any pre-existing kidney, liver, heart, or pancreatic conditions, or significant alcohol consumption before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Potential drug interactions exist; disclose all medications to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Your physician will monitor kidney function and blood glucose levels throughout treatment.

Uses of Jubivilda 50 M Tablet SR

Managing type 2 diabetes

Major Benefits of Jubivilda 50 M Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for Jubivilda 50 M Tablet SR. Ingest the tablet whole; do not break, crush, or chew it. Take this medication with food.

Common Side effects of Jubivilda 50 M Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Jubivilda 50 M Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Jubivilda 50 M Tablet SR whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

How Jubivilda 50 M Tablet SR works:

Jubivilda 50 mg Extended-Release Tablets contain a dual-action antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Jubivilda 50 M Tablet SR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Jubivilda 50 mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Jubivilda 50 mg tablets are likely not safe for use while breastfeeding. Available human data indicate potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

For individuals with kidney impairment, the extended-release Jubivilda 50 mg tablet requires careful administration. Dosage modification may be necessary; physician consultation is advised.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Jubivilda 50 M Tablet SR due to potential safety concerns. Medical advice is recommended.

What if you forget to take Jubivilda 50 M Tablet SR :

Should you forget a dose of Jubivilda 50 M Tablet SR, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Jubivilda 50 M Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Jubivilda 50 M Tablet SR

Jubivilda 50 M Tablet SR rarely causes hypoglycemia by itself; however, insufficient caloric intake while using it may lead to low blood sugar. Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness, particularly if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Regular blood sugar monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is advisable.
Nausea and vomiting are possible side effects of Jubivilda 50 M Tablet SR. If vomiting occurs, sip small amounts of water or other fluids frequently. Persistent vomiting or dehydration symptoms (dark, strong-smelling urine, infrequent urination) warrant immediate medical attention. Consult your doctor before taking any other medication.
Patients with allergies to Jubivilda 50 M Tablet SR components or excipients, or those suffering from severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Jubivilda 50 M Tablet SR combines metformin (a biguanide) and vildagliptin to manage diabetes. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This medication is unsuitable for individuals under 18.
Lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as MALA when associated with metformin), is a potential, though rare, side effect of Jubivilda 50 M Tablet SR. This risk is heightened in patients with kidney disease, the elderly, and heavy alcohol users, hence its avoidance in these groups. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. Should these symptoms occur, discontinue Jubivilda 50 M Tablet SR and seek immediate medical attention.
Prolonged use of Jubivilda 50 M Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia and neurological complications.
Using Jubivilda 50 M Tablet SR as directed by your doctor is safe. However, even with correct usage, side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, and low blood sugar (if also taking insulin or sulphonylurea) may occur. Report any persistent issues to your doctor.
Jubivilda 50 M Tablet SR
114
MRP 139
18% off